Amazon Pharmacy offers GLP-1 drugs to Medicare patients at $50/month

Amazon (NASDAQ: AMZN) announced that its pharmacy service will now offer GLP-1 medications, including Wegovy, Zepbound, and Foundayo, to eligible Medicare Part D patients for $50 per month.

Amazon Pharmacy said same-day delivery of GLP-1 medications is currently available in more than 3,100 U.S. cities, with plans to expand to nearly 4,500 cities by the end of 2026.

You May Also Be Interested In

• Amazon invests $1.9B in delivery partner program, adds AI tools
• Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold
• Meesho Ltd (MESSHO:IN) PT Raised to INR260 at UBS